Comparing home-based and hospital-based pulmonary rehabilitation for bronchiectasis
Comparison of Pulmonary Rehabilitation Efficiency in Home-based With Hospital-based Pulmonary Rehabilitation in Bronchiectasis
This study is testing whether doing pulmonary rehabilitation at home or in the hospital is better for people with bronchiectasis to see which helps them breathe easier and feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Istanbul Medipol University Hospital Academic / other |
| Locations | 1 site (Istanbul, Zeytinburnu) |
| Trial ID | NCT03561818 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness of home-based pulmonary rehabilitation (PR) versus hospital-based PR in patients with bronchiectasis. While PR has shown benefits in chronic obstructive pulmonary disease (COPD), its efficacy in bronchiectasis is less understood, necessitating further investigation. The study will assess pulmonary function, dyspnea perception, quality of life, and exercise capacity before and after the rehabilitation programs. By evaluating both supervised and unsupervised PR methods, the research seeks to determine the most effective approach for improving patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-70 with stable bronchiectasis diagnosed via high-resolution computed tomography.
Not a fit: Patients with decompensated heart failure, uncontrolled hypertension, or other conditions that may hinder exercise will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into more accessible and effective rehabilitation options for patients with bronchiectasis.
How similar studies have performed: While some studies have shown positive effects of pulmonary rehabilitation in bronchiectasis, this specific comparison of home-based versus hospital-based approaches is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between the ages of 18-70 * Patients signing informed consent form * Bronchiectasis patients in the stable phase who were diagnosed with High-resolution computed tomography (HRCT). Exclusion Criteria: * Decompensated heart failure, uncontrolled hypertension (Systolic Blood Pressure\> 200, Diastolic Blood Pressure\> 110), * Additional diseases that may prevent exercise, * To be regularly exercising regularly
Where this trial is running
Istanbul, Zeytinburnu
- Yedikule Chest Disease Hospital — Istanbul, Zeytinburnu, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Esra Pehlivan, PhD
- Email: fztesrakambur@yahoo.com
- Phone: +905058527913
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.